stockrow
Saturday 7 November 2026
Export DMRA’s income statement to Excel — free account
Galecto, Inc.
DMRA Healthcare Biotechnology
- EPS
- +78.1%
- Free cash flow
- −877.5%
Quarter to September 2026, against a year earlier
23.67
1.81
+8.28%
Follow DMRA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (39.51%) | (26.26%) | (12.37%) | 6.72% |
+8 more TTM periods Free account |
|
| (27.08%) | (18.64%) | (8.79%) | (3.90%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(14.85%) | (10.07%) | (4.73%) | (2.25%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.96) | (0.73) | (0.73) | (4.93) | |
Free Cash Flow |
(59.13) | (44.51) | (24.88) | (6.73) | |
| Other line items | |||||
Cash ROIC |
(5.77%) | (4.21%) | (2.38%) | (1.35%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.80 | 0.86 | 1.03 | 1.24 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.96) | (0.73) | (0.73) | (4.93) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026